GINA 2024 Asthma Update: Revised Recommendations on …
Jun 28, 2024 · The GINA 2024 asthma update includes new guidance on medications, monitoring, treatment goals, remission, cough variant asthma, children, and more.
Air Embolism | Diagnosis & Disease Information - Pulmonology …
Apr 29, 2024 · Air embolism is a rare but potentially life-threatening medical condition that occurs when air bubbles enter the bloodstream, which can block the flow of blood to vital organs. 1,2 When an air bubble enters a vein, it is referred to as a venous air embolism, while an air bubble entering an artery is an arterial air embolism. 1 Epidemiology and Etiology of Air Embolism
GOLD COPD Report 2025: Key Spirometry and Drug Updates
Nov 22, 2024 · The 2025 GOLD COPD report, titled “Global Strategy for Prevention, Diagnosis and Management of COPD: 2025 Report,” can now be downloaded from the GOLD website, along with a pocket guide to the report and the “2025 …
Restrictive Lung Diseases | Diagnosis & Disease Information
Restrictive lung diseases are respiratory disorders marked by diminished lung capacity stemming from a wide range of underlying factors, including changes in lung parenchyma or conditions that affect the pleura, chest wall, or neuromuscular system. 1 Restrictive lung diseases can be classified as pulmonary parenchyma diseases (intrinsic causes) or extrapulmonary diseases (extrinsic causes ...
FDA Drug Approval Decisions Expected in November 2024
Oct 7, 2024 · The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA) and making a final decision on marketing approval. The typical period for review is 10 months after the drug application has been accepted by the Agency.
2024 GOLD Report Reflects New Research on COPD Management
Dec 8, 2023 · The 2024 GOLD Report, “Global Strategy for Prevention Diagnosis and Management of COPD,” not only includes guideline updates that reflect the latest research on chronic obstructive pulmonary disease (COPD); it also reflects some shifts in thinking about what’s important in COPD treatment, according to Claus Vogelmeier, MD, a lead report author and science committee chair for the Global ...
CT Honeycombing in Interstitial Lung Disease ... - Pulmonology …
Feb 11, 2019 · Patients with interstitial lung disease (ILD) who had honeycombing on chest computed tomography (CT) had higher mortality rates than patients without honeycombing, according to study results published in the Annals of the American Thoracic Society.. Medical records were examined from adult participants with either multidisciplinary or adjudicated ILD diagnosis who had a chest CT scan at diagnosis.
Hemorrhagic Pleural Effusion - Pulmonology Advisor
Nov 15, 2023 · Presentation and Cause. The pleural space, which is situated between the parietal and visceral pleura, typically has 7 to 16 ml of fluid. 1 Hemorrhagic pleural effusion occurs when excess fluid accumulates in this space due to fluid production exceeding the removal rate. There are many etiologies that can cause pleural effusion.
Nebulized Anticholinergic Therapy for Maintenance Treatment of …
For select patients with COPD, nebulized drugs might offer an alternative to a breath-actuated, hand-held inhaler. 5 Adherence to inhaled medication in patients with COPD is low, with the nonadherence rate ranging from 50% to 80%. 6 Among the causes of nonadherence is the inability to use an inhaler as directed. 6 Inhalers can be nearly impossible to use for patients who have a low inspiratory ...
Diagnosis & Disease Information - Pulmonology Advisor
Apr 5, 2024 · Hemothorax is a collection of blood in the pleural space that is often the result of a traumatic injury. 1 Symptoms of hemothorax include chest pain and shortness of breath. Potential late complications include empyema and fibrothorax, which can lead to lung entrapment or collapse and respiratory failure. 1 Rapid evaluation and diagnosis are crucial for symptom relief and optimal patient outcomes.